Showing results (1681-1690 of 2,081) with videos related to

Sort By:
Pageof 209
Trials|February 27, 2021
Acupuncture in diabetic peripheral neuropathy-protocol for the randomized, multicenter ACUDPN trialJ Dietzel, S Hörder, I V Habermann, et al.
The Lancet. Haematology|May 30, 2020
Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trialGita Thanarajasingam, John P Leonard, Thomas E Witzig, et al.
Haematologica|April 21, 2019
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman diseaseGaurav Goyal, Aishwarya Ravindran, Jason R Young, et al.
Cellular and Molecular Life Sciences : CMLS|July 9, 2011
Protein profiling of genomic instability in endometrial cancerTimo Gemoll, Jens K Habermann, Johanna Lahmann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 1, 2013
Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern eraA M Evens, S Choquet, A R Kroll-Desrosiers, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 22, 2010
Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphomaJennifer L Kelly, Anne J Novak, Zachary S Fredericksen, et al.
British Journal of Haematology|August 8, 2006
Absolute lymphocyte count predicts overall survival in follicular lymphomasMustaqeem Siddiqui, Kay Ristow, Svetomir N Markovic, et al.
International Journal of Cancer|December 23, 2008
The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcomeJens K Habermann, Jana Doering, Sampsa Hautaniemi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2012
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 regionJames R Cerhan, Zachary S Fredericksen, Anne J Novak, et al.
Cancer Cell|June 15, 2013
SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomasLinfeng Chen, Stefano Monti, Przemyslaw Juszczynski, et al.
Pageof 209